Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis

Fig. 1

Network geometry of the direct comparison in the eligible 16 RCTs. Network (a) expressed individual drugs or their combinations as each node, and a direct comparison of two different treatments in an RCT was shown as a line between nodes. Network (b) combined all inhaled treatments other than individual LAMA/LABAs to each drug class (ICS/LAMA/LABA, ICS/LABA, LAMA, and LABA) and expressed them as each node. The number of direct comparison was expressed as a number in the middle of a line between nodes. ACL aclidinium, BEC beclomethasone, FOR formoterol, FLU fluticasone, GLY glycopyrrolate, IND indacaterol, OLO olodaterol, PBO, placebo, SAL salmeterol, TIO tiotropium, UME umeclidinium, VIL vilanterol

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us